Lenalidomid Krka
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Lenalidomid Krka |
|---|---|
| Former Name | Lenalidomid Krka d.d. Novo mesto |
| Active Substance | lenalidomidklorid hidrat |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| ATC Code | L04AX04 |
| Marketing status | nije stavljeno u promet |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
Vodic za zdravstvene radnike, verzija 5, travanj 2025 Obrazac za prijavu trudnoće, verzija 3, travanj 2025 Obrazac potvrde bolesnice u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde bolesnice koja nije u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde muškog bolesnika, verzija 1, travanj 2025 |
| Educational materials for patients / caregivers |
Kartica za bolesnika, verzija 4, travanj 2025 Vodic za bolesnice u reproduktivnoj dobi i njihove partnere, verzija 1 travanj 2025 Vodic za bolesnice koje nisu u reproduktvnoj dobi, verzija 1 travanj 2025 Vodic za muške bolesnike, verzija1, travanj 2025 |
